Search Results - Ingrid A M Gisbertz

Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled... by Reinier C A van Linschoten, Fenna M. Jansen, R Pauwels, Lisa Smits, Femke Atsma, Wietske Kievit, Dirk J. de Jong, Annemarie C. de Vries, Paul J. Boekema, Rachel West, Alexander Bodelier, Ingrid A M Gisbertz, Frank H.J. Wolfhagen, Tessa E H Römkens, Maurice Lutgens, Adriaan A. van Bodegraven, Bas Oldenburg, Marieke Pierik, Maurice G. Rüssel, Nanne K.H. de Boer, Rosalie C. Mallant–Hent, Pieter C. J. ter Borg, Andrea E. van der Meulen‐de Jong, Jeroen M. Jansen, Sita V Jansen, Adrianus C I T L Tan, C. Janneke van der Woude, Frank Hoentjen, Désirée van Noord, Jildou Hoekstra, Johannes T. Kamphuis, Moniek H.P. Gorter, Aura A. J. van Esch

Get full text